Research analysts at Bank of America Corp. set a $90.00 price target on shares of Illumina (NASDAQ:ILMN) stock in a report released on Thursday, American Banking & Market News reports. The firm currently has a a “buy” rating on the stock. Bank of America Corp.’s price target points to a potential upside of 12.88% from the stock’s previous close.
Shares of Illumina (NASDAQ:ILMN) traded down 0.38% during mid-day trading on Thursday, hitting $79.43. The stock had a trading volume of 17,641 shares. Illumina has a 52-week low of $40.71 and a 52-week high of $83.23. The stock’s 50-day moving average is $77.52 and its 200-day moving average is $68.54. The company has a market cap of $9.938 billion and a P/E ratio of 93.80.
Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter in the previous year, the company posted $0.40 earnings per share. The company’s revenue for the quarter was up 23.3% on a year-over-year basis. Analysts expect that Illumina will post $1.72 EPS for the current fiscal year.
ILMN has been the subject of a number of other recent research reports. Analysts at Janney Montgomery Scott initiated coverage on shares of Illumina in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock. Separately, analysts at Wedbush raised their price target on shares of Illumina from $55.00 to $60.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Illumina from $72.00 to $84.00 in a research note to investors on Wednesday, July 24th. They now have an “outperform” rating on the stock.
One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $73.81.
In other Illumina news, SVP Nicholas Naclerio sold 2,000 shares of the stock in a transaction that occured on Thursday, August 15th. The shares were sold at an average price of $78.43, for a total value of $156,860.00. Following the sale, the senior vice president now directly owns 24,559 shares of the company’s stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.